Mager DE - Search Results

1

Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.

Ramakrishnan S, Cortes-Gomez E, Athans SR, Attwood KM, Rosario SR, Kim SJ, Mager DE, Isenhart EG, Hu Q, Wang J, Woloszynska A. Ramakrishnan S, et al. Among authors: mager de. Genome Med. 2024 Apr 2;16(1):52. doi: 10.1186/s13073-024-01323-6. Genome Med. 2024. PMID: 38566104 Free PMC article. Review.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38579886

3

Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models.

Wang J, Chen T, Ruszaj DM, Mager DE, Straubinger RM. Wang J, et al. Among authors: mager de. J Pharm Sci. 2024 Jan;113(1):72-84. doi: 10.1016/j.xphs.2023.10.019. Epub 2023 Oct 14. J Pharm Sci. 2024. PMID: 37844759

4

Contributions of William Jusko to Development of Pharmacokinetic and Pharmacodynamic Models and Methods.

Mager DE, Straubinger RM. Mager DE, et al. J Pharm Sci. 2024 Jan;113(1):2-10. doi: 10.1016/j.xphs.2023.09.019. Epub 2023 Sep 30. J Pharm Sci. 2024. PMID: 37778439 No abstract available.

5

Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assays.

Derippe T, Fouliard S, Decleves X, Mager DE. Derippe T, et al. Among authors: mager de. CPT Pharmacometrics Syst Pharmacol. 2024 May 15. doi: 10.1002/psp4.13158. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38747730 Free article.

6

Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.

McCune JS, Armenian SH, Nakamura R, Shan H, Kanakry CG, Mielcarek M, Gao W, Mager DE. McCune JS, et al. Among authors: mager de. J Oncol Pharm Pract. 2024 Mar;30(2):322-331. doi: 10.1177/10781552231171607. Epub 2023 May 3. J Oncol Pharm Pract. 2024. PMID: 37134196

7

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.

Li R, Craig M, D'Argenio DZ, Betts A, Mager DE, Maurer TS. Li R, et al. Among authors: mager de. Front Pharmacol. 2023 Apr 12;14:1184914. doi: 10.3389/fphar.2023.1184914. eCollection 2023. Front Pharmacol. 2023. PMID: 37124233 Free PMC article. No abstract available.

8

Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting Enzyme.

Nguyen VA, Zhang L, Kagan L, Rowland M, Mager DE. Nguyen VA, et al. Among authors: mager de. J Pharm Sci. 2024 Jan;113(1):167-175. doi: 10.1016/j.xphs.2023.10.025. Epub 2023 Oct 21. J Pharm Sci. 2024. PMID: 37871777

9

Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Lin LH, Ghasemi M, Burke SM, Mavis CK, Nichols JR, Torka P, Mager DE, Hernandez-Ilizaliturri FJ, Goey AKL. Lin LH, et al. Among authors: mager de. Target Oncol. 2023 Sep;18(5):685-695. doi: 10.1007/s11523-023-00992-4. Epub 2023 Aug 26. Target Oncol. 2023. PMID: 37632592 Clinical Trial.

10

Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia.

Derippe T, Fouliard S, Marchiq I, Dupouy S, Almena-Carrasco M, Geronimi J, Declèves X, Chenel M, Mager DE. Derippe T, et al. Among authors: mager de. Cancer Res Commun. 2022 Nov 30;2(11):1532-1544. doi: 10.1158/2767-9764.CRC-22-0176. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page